3rd Quarter - Report

SQUIRE PATTON BOGGS for BAXTER HEALTHCARE CORPORATION

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug and biological product pricing and reimbursement; Medical product safety; Prescription drug pedigree and anti-counterfeiting policy; Drug and device marketing and promotion; Healthcare-acquired infections; H.R. 5629, Pathway for Biosimilars Act; Implementation of P.L. 110-85/H.R. 3580, Food and Drug Administration Amendments Act of 2007; Comparative effectiveness research.

LobbyistCovered position, as disclosed
BRET KOPLOW —

Bills named: H.R. 5629 (110th), H.R. 3580 (110th)

Medicare/Medicaid MMM

Drug and biological product pricing and reimbursement; Medical product safety; Prescription drug pedigree and anti-counterfeiting policy; Drug and device marketing and promotion; Healthcare-acquired infections; H.R. 5629, Pathway for Biosimilars Act; Implementation of P.L. 110-85/H.R. 3580, Food and Drug Administration Amendments Act of 2007; Comparative effectiveness research.

LobbyistCovered position, as disclosed
BRET KOPLOW —

Bills named: H.R. 3580 (110th), H.R. 5629 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.